COVID-19 pandemic dynamics in India and impact of the SARS-CoV-2 Delta (B.1.617.2) variant
View ORCID ProfileWan Yang, Jeffrey Shaman
doi: https://doi.org/10.1101/2021.06.21.21259268
Wan Yang
1Department of Epidemiology, Columbia University, New York, NY, USA
Jeffrey Shaman
2Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA
Data Availability
All data used in this study are publicly available as described in the Data sources and processing section.
Posted June 25, 2021.
COVID-19 pandemic dynamics in India and impact of the SARS-CoV-2 Delta (B.1.617.2) variant
Wan Yang, Jeffrey Shaman
medRxiv 2021.06.21.21259268; doi: https://doi.org/10.1101/2021.06.21.21259268
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)